J43.2

Clinical Causes: Prolonged cigarette smoking is the primary cause. Exposure to air pollution, including occupational hazards like dust and chemicals. Genetic factors that may predispose individuals to lung tissue damage. History of respiratory infections that may contribute to lung deterioration. Chronic inhalation of irritants that lead to inflammation and destruction of alveoli.

Key Symptoms: Shortness of breath, especially during physical activity or exertion. Persistent cough that may produce sputum. Wheezing or a whistling sound during breathing. Chest tightness or discomfort. Fatigue due to decreased oxygen levels. Frequent respiratory infections. Weight loss in advanced stages of the disease.

Diagnosis Path: Diagnosis of centrilobular emphysema typically involves a combination of medical history review, physical examination, and diagnostic tests. Pulmonary function tests (PFTs) are critical in assessing airflow limitation and lung capacity. Imaging studies like chest X-rays and high-resolution computed tomography (HRCT) scans provide detailed visualization of lung tissue, revealing areas of alveolar destruction and confirming the diagnosis.

Treatment Protocols: While there is no cure for centrilobular emphysema, management aims to alleviate symptoms, prevent progression, and improve quality of life. Treatment options include: - Smoking cessation programs to halt disease progression. - Bronchodilator medications to open airways and reduce symptoms. - Pulmonary rehabilitation programs focusing on exercise, education, and support. - Vaccinations such as influenza and pneumococcal vaccines to reduce respiratory infections. - Oxygen therapy in cases of significant oxygen deficiency. - Surgical options like lung volume reduction surgery or bullectomy in severe cases. - Lifestyle adjustments, including avoiding lung irritants and maintaining good nutrition.